Yaojuan Lu

1.1k total citations
41 papers, 893 citations indexed

About

Yaojuan Lu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yaojuan Lu has authored 41 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 12 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Yaojuan Lu's work include Osteoarthritis Treatment and Mechanisms (10 papers), Bone Metabolism and Diseases (9 papers) and Cancer-related Molecular Pathways (7 papers). Yaojuan Lu is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (10 papers), Bone Metabolism and Diseases (9 papers) and Cancer-related Molecular Pathways (7 papers). Yaojuan Lu collaborates with scholars based in China, United States and Taiwan. Yaojuan Lu's co-authors include Qiping Zheng, Junxia Gu, Longwei Qiao, Feifei Li, Ping Zhang, Lu Zhang, Michael Sheldon, Xiaojun Xu, Ming Ding and Caihong Sun and has published in prestigious journals such as Annals of Neurology, Biochemical and Biophysical Research Communications and Journal of Bone and Mineral Research.

In The Last Decade

Yaojuan Lu

41 papers receiving 887 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaojuan Lu China 16 537 233 213 142 113 41 893
Karyn Bouhana United States 13 560 1.0× 295 1.3× 192 0.9× 43 0.3× 73 0.6× 26 946
Paola Bonetti Italy 21 854 1.6× 201 0.9× 236 1.1× 152 1.1× 43 0.4× 38 1.8k
Tomoko Hashimoto-Tamaoki Japan 19 579 1.1× 140 0.6× 308 1.4× 170 1.2× 79 0.7× 45 1.2k
Joseph L. Lasky United States 13 430 0.8× 163 0.7× 193 0.9× 38 0.3× 42 0.4× 36 852
So Young Chong South Korea 15 637 1.2× 195 0.8× 129 0.6× 92 0.6× 36 0.3× 52 1.1k
Elisa Bianchi Italy 17 465 0.9× 161 0.7× 70 0.3× 117 0.8× 40 0.4× 35 900
Xianding Sun China 9 449 0.8× 83 0.4× 89 0.4× 102 0.7× 77 0.7× 17 731
Muthurangan Manikandan Saudi Arabia 17 407 0.8× 169 0.7× 136 0.6× 48 0.3× 33 0.3× 38 738
Weijia Sun China 12 560 1.0× 275 1.2× 138 0.6× 53 0.4× 44 0.4× 22 937
Rossana Domenis Italy 19 687 1.3× 305 1.3× 98 0.5× 127 0.9× 39 0.3× 40 1.2k

Countries citing papers authored by Yaojuan Lu

Since Specialization
Citations

This map shows the geographic impact of Yaojuan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaojuan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaojuan Lu more than expected).

Fields of papers citing papers by Yaojuan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaojuan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaojuan Lu. The network helps show where Yaojuan Lu may publish in the future.

Co-authorship network of co-authors of Yaojuan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yaojuan Lu. A scholar is included among the top collaborators of Yaojuan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaojuan Lu. Yaojuan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Biaohua, Fangzhou Chen, Xuan Wu, et al.. (2023). DLX5 promotes Col10a1 expression and chondrocyte hypertrophy and is involved in osteoarthritis progression. Genes & Diseases. 10(5). 2097–2108. 10 indexed citations
2.
Chen, Biaohua, Ruoxuan Hei, Chen Chen, et al.. (2023). CircCRIM1 suppresses osteosarcoma progression via sponging miR146a-5p and targeting NUMB.. PubMed. 13(8). 3463–3481. 3 indexed citations
3.
Gu, Yu, Chen Chen, Biaohua Chen, et al.. (2023). Silence of URI in gastric cancer cells promotes cisplatin-induced DNA damage and apoptosis.. PubMed. 13(3). 936–949. 6 indexed citations
4.
Hei, Ruoxuan, Biaohua Chen, Xiaojing Zhang, et al.. (2022). CircNRIP1 acts as a sponge of miR-1200 to suppress osteosarcoma progression via upregulation of MIA2.. PubMed. 12(6). 2833–2849. 3 indexed citations
5.
Zhu, Ting, Yuting Liang, Ruoxuan Hei, et al.. (2021). Expression Profiling and Functional Analysis of Candidate Col10a1 Regulators Identified by the TRAP Program. Frontiers in Genetics. 12. 683939–683939. 10 indexed citations
6.
Zhang, Ping, Lei Liu, Lu Zhang, et al.. (2020). Runx2 is required for activity of CD44+/CD24-/low breast cancer stem cell in breast cancer development.. PubMed. 12(5). 2305–2318. 17 indexed citations
7.
Qiao, Longwei, Qin Zhang, Ang Gao, et al.. (2019). Sequencing of short cfDNA fragments in NIPT improves fetal fraction with higher maternal BMI and early gestational age.. PubMed. 11(7). 4450–4459. 22 indexed citations
8.
Xu, Xiaodan, Lu Zhang, Ping Zhang, et al.. (2018). TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis. Biochemical and Biophysical Research Communications. 502(1). 160–165. 137 indexed citations
9.
Zhu, Ting, Longwei Qiao, Qian Wang, et al.. (2017). T-box family of transcription factor-TBX5, insights in development and disease.. PubMed. 9(2). 442–453. 16 indexed citations
10.
Hu, Xiaoxia, Fei Zhang, Na Li, et al.. (2016). URI prevents potassium dichromate-induced oxidative stress and cell death in gastric cancer cells.. PubMed. 8(12). 5399–5409. 15 indexed citations
11.
Li, Na, Xiaoxia Hu, Wei Luo, et al.. (2015). RUNX2 and Osteosarcoma. Anti-Cancer Agents in Medicinal Chemistry. 15(7). 881–887. 35 indexed citations
12.
Lu, Yaojuan, Steven Gitelis, Guanghua Lei, et al.. (2014). Research findings working with the p53 and Rb1 targeted osteosarcoma mouse model.. PubMed. 4(3). 234–44. 9 indexed citations
13.
Lu, Yaojuan, Sam Abbassi, Feifei Li, et al.. (2013). Distinct function of P63 isoforms during embryonic skeletal development. Gene. 519(2). 251–259. 10 indexed citations
14.
Gu, Junxia, Xiaoyun Li, Yuting Liang, et al.. (2013). Upregulation of URI/RMP gene expression in cervical cancer by high-throughput tissue microarray analysis.. PubMed. 6(4). 669–77. 12 indexed citations
15.
Gu, Junxia, Yuting Liang, Longwei Qiao, et al.. (2013). Expression analysis of URI/RMP gene in endometrioid adenocarcinoma by tissue microarray immunohistochemistry.. PubMed. 6(11). 2396–403. 22 indexed citations
16.
Li, Feifei, Yaojuan Lu, Ming Ding, et al.. (2012). Putative function of TAP63α during endochondral bone formation. Gene. 495(2). 95–103. 12 indexed citations
17.
Ding, Ming, Yaojuan Lu, Sam Abbassi, et al.. (2011). Targeting Runx2 expression in hypertrophic chondrocytes impairs endochondral ossification during early skeletal development. Journal of Cellular Physiology. 227(10). 3446–3456. 60 indexed citations
18.
Lu, Xinyan, Yaojuan Lu, Jason Kang, et al.. (2008). Cell Cycle Regulator Gene CDC5L , a Potential Target for 6p12-p21 Amplicon in Osteosarcoma. Molecular Cancer Research. 6(6). 937–946. 65 indexed citations
19.
Ljungberg, M. Cecilia, Meenakshi B. Bhattacharjee, Yaojuan Lu, et al.. (2006). Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia. Annals of Neurology. 60(4). 420–429. 128 indexed citations
20.
Zhou, Yu, T.C. Lei, & Yaojuan Lu. (1992). Grain growth and phase separation of ZrO2-Y2O3 ceramics annealed at high temperature. Ceramics International. 18(4). 237–242. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026